267 related articles for article (PubMed ID: 17130682)
1. A prospective survey on safety of sustained-release theophylline in treatment of asthma and COPD.
Makino S; Adachi M; Ohta K; Kihara N; Nakajima S; Nishima S; Fukuda T; Miyamoto T; ;
Allergol Int; 2006 Dec; 55(4):395-402. PubMed ID: 17130682
[TBL] [Abstract][Full Text] [Related]
2. Prospective survey on safety evaluation of injectable methylxanthines in Japan.
Ohta K; Makino S; Adachi M; Kihara N; Nakajima S; Nishima S; Fukuda T; Miyamoto T
Allergol Int; 2006 Sep; 55(3):295-9. PubMed ID: 17075270
[TBL] [Abstract][Full Text] [Related]
3. A prospective clinical study of theophylline safety in 3810 elderly with asthma or COPD.
Ohta K; Fukuchi Y; Grouse L; Mizutani R; Rabe KF; Rennard SI; Zhong NS
Respir Med; 2004 Oct; 98(10):1016-24. PubMed ID: 15481279
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of the efficacy and safety of theophylline and doxofylline in patients with bronchial asthma and chronic obstructive pulmonary disease.
Lal D; Manocha S; Ray A; Vijayan VK; Kumar R
J Basic Clin Physiol Pharmacol; 2015 Sep; 26(5):443-51. PubMed ID: 25894641
[TBL] [Abstract][Full Text] [Related]
5. [Corrected conclusion in the SBU report: no supplementary effect of theophylline in acute, moderate asthma, but this is not documented in severe life-threatening asthma].
Eliasson M; Sandström T; Boman G
Lakartidningen; 2001 Sep; 98(37):3961. PubMed ID: 11586839
[No Abstract] [Full Text] [Related]
6. [Development of theophylline in treatment of asthma and chronic obstructive pulmonary disease].
Xu YJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):319-22. PubMed ID: 15266839
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma -- a double-blind randomized placebo-controlled multicentre clinical trial.
Goldstein MF; Chervinsky P
Med Sci Monit; 2002 Apr; 8(4):CR297-304. PubMed ID: 11951074
[TBL] [Abstract][Full Text] [Related]
8. The theophylline dilemma.
Vadász I
Ther Hung; 1992; 40(1):3-7. PubMed ID: 1585282
[TBL] [Abstract][Full Text] [Related]
9. Risk of emergency care, hospitalization, and ICU stays for acute asthma among recipients of salmeterol.
Lanes SF; Lanza LL; Wentworth CE
Am J Respir Crit Care Med; 1998 Sep; 158(3):857-61. PubMed ID: 9731017
[TBL] [Abstract][Full Text] [Related]
10. A randomized open-label comparative study of montelukast versus theophylline added to inhaled corticosteroid in asthmatic children.
Kondo N; Katsunuma T; Odajima Y; Morikawa A
Allergol Int; 2006 Sep; 55(3):287-93. PubMed ID: 17075269
[TBL] [Abstract][Full Text] [Related]
11. [Bamifylline in the therapy of asthmatic syndromes. Efficacy and side effects vs delayed-action theophylline anhydride].
Alciato P; Cantone PA; Fico D; Gagliardini R; Petrella V
Minerva Med; 1990; 81(1-2):93-7. PubMed ID: 2314621
[TBL] [Abstract][Full Text] [Related]
12. Comparison of a short course of prednisolone with sustained-release theophylline in the control of nocturnal asthma.
Chhabra SK
Indian J Chest Dis Allied Sci; 1995; 37(1):7-14. PubMed ID: 16892732
[TBL] [Abstract][Full Text] [Related]
13. [Clinical experiences with a new drug association with anti-asthmatic action].
Martelli A
Clin Ter; 1967 Jun; 41(6):529-44. PubMed ID: 4387419
[No Abstract] [Full Text] [Related]
14. Spanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish Society of Pulmonology and Thoracic Surgery.
Miravitlles M; Soler-Cataluña JJ; Calle M; Molina J; Almagro P; Quintano JA; Riesco JA; Trigueros JA; Piñera P; Simón A; López-Campos JL; Soriano JB; Ancochea J;
Arch Bronconeumol; 2012 Jul; 48(7):247-57. PubMed ID: 22561012
[TBL] [Abstract][Full Text] [Related]
15. [The anti-inflammatory action of an oral sustained-release theophylline preparation. Results of a clinical pilot study with low dosages].
Bodner A; Hens C; Moser C; Oster H
Arzneimittelforschung; 1998 May; 48(5A):617-24. PubMed ID: 9676355
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic action of a drug with constant and prolonged release (Netaprina Dospan) in the treatment of various obstructive broncho-pneumopathies].
Fontana A; Ballerini G
Policlinico Prat; 1970 Sep; 77(39):1247-54. PubMed ID: 4394634
[No Abstract] [Full Text] [Related]
17. Conversion from twice- to once-daily extended-release theophylline treatment in patients with reversible airway obstruction.
Berkowitz RB; Tinkelman DG; Marcoux JP; Rooklin AR; Zeitz HJ; Rennard SI; Moss BA; Hubbard RC; Lorber RR
J Asthma; 1995; 32(4):275-84. PubMed ID: 7629003
[TBL] [Abstract][Full Text] [Related]
18. [Experiences in the treatment of bronchospastic diseases].
Klein HG
Med Welt; 1967 Nov; 45():2718-21. PubMed ID: 5609213
[No Abstract] [Full Text] [Related]
19. [Slow-release theophylline for the treatment of asthmatic children].
Iwasaki E; Baba M
Nihon Rinsho; 1996 Nov; 54(11):3102-7. PubMed ID: 8950962
[TBL] [Abstract][Full Text] [Related]
20. Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year.
Zhou Y; Wang X; Zeng X; Qiu R; Xie J; Liu S; Zheng J; Zhong N; Ran P
Respirology; 2006 Sep; 11(5):603-10. PubMed ID: 16916334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
